Article
Somatic mutational spectrum analysis in a prospective series of 104 gastrointestinal stromal tumors.
Oncology reports - 1 Mar 2017
Guenat David, Deroo Olivier, Magnin Sandrine, Chaigneau Loïc, Monnien Franck, Borg Christophe, Mougin Christiane, Emile Jean-François, Prétet Jean-Luc
Abstract excerpt
Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors distinguished by driver mutations in proto-oncogenes KIT or PDGFRA in 85-90% of cases. These mutations have been linked to the response to imatinib, a multikinase inhibitor, and have independent prognostic impact. Here, we describe the prospective study of the molecular characteristics of 104 GISTs from French adult patients analyzed routinely through...
Topics
- Adult
- Aged
- Aged, 80 and over
- Biomarkers, Tumor
- Exons
- Female
- Gastrointestinal Neoplasms
- Gastrointestinal Stromal Tumors
- Humans
- Male
- Middle Aged
